Author:
Mackey John,McLeod Deanna,Ragaz Joseph,Gelmon Karen,Verma Sunil,Pritchard Kathleen,Laing Kara,Provencher Louise,Charbonneau Lauren F.
Reference46 articles.
1. Multicenter, randomized phase III study of adjuvant chemotherapy for node positive breast cancer comparing 6 cycles of FE90C versus 4 cycles of FE90C followed by 8 weekly paclitaxel administrations: interim efficacy analysis of GEICAM 9906 trial [abstract];Martin;Breast Cancer Res Treat,2005
2. Adjuvant docetaxel for node-positive breast cancer;Martin;N Engl J Med,2005
3. Phase III study of doxorubicin-cyclophosphamide followed by paclitaxel or docetaxel given every 3 weeks or weekly in operable breast cancer: results of Intergroup Trial E1199 [abstract]. 2007 ASCO Annual Meeting Proceedings, Part I (June 20 Supplement);Sparano;J Clin Oncol,2007
4. Untangling the ErbB signaling network;Yarden;Nat Rev Mol Cell Biol,2001
5. Biologic and therapeutic role of HER2 in cancer;Menard;Oncogene,2003
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献